FDA inspection
Halo Pharmaceutical Canada Inc: FDA inspection ending Nov 14, 2014
FDA inspection 903523 · Voluntary Action Indicated (VAI) · Mirabel
Key facts
| Inspection ID | 903523 |
|---|---|
| Firm | Halo Pharmaceutical Canada Inc |
| FEI number | 3009856628 |
| Address | 17800 Lapointe St |
| City | Mirabel |
| Country | Canada |
| Fiscal year | 2015 |
| Inspection end date | Nov 14, 2014 |
| Classification | Voluntary Action Indicated (VAI) |
| Project area | Drug Quality Assurance |
| Product type | Drugs |
At a glance
- 1–9 Citations
- 1–9 Posted citations
- No Warning letter followed
- Yes Form FDA 483 issued
- No Establishment inspection report (EIR) exists
- 1–9 Inspections at this FEI
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About FDA inspections
FDA inspections are classified as No Action Indicated (NAI), Voluntary Action Indicated (VAI) or Official Action Indicated (OAI). Inspections of individual clinical investigators are not published here.
Source: U.S. Food and Drug Administration (FDA), inspection classification data